Podcasts about medicine humanities science show id

According to the World Health Organization (WHO) an estimated 1.3 billion people or 16% of the global population have a significant disability. A disability is a condition that can be mental or physical, and can affect a person's vision, movement, thinking, learning, communication, hearing, mental health or social relationships. However, not all disabilities are the same. Some disabilities are genetic, passed down from generation to generation, while others may have been caused by an incident out of the person's control. In this episode of Exploring Ethics, Professor Joseph Stramondo will discuss the narrative, identity and ethics of choosing disability. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 40241]

According to the World Health Organization (WHO) an estimated 1.3 billion people or 16% of the global population have a significant disability. A disability is a condition that can be mental or physical, and can affect a person's vision, movement, thinking, learning, communication, hearing, mental health or social relationships. However, not all disabilities are the same. Some disabilities are genetic, passed down from generation to generation, while others may have been caused by an incident out of the person's control. In this episode of Exploring Ethics, Professor Joseph Stramondo will discuss the narrative, identity and ethics of choosing disability. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 40241]

According to the World Health Organization (WHO) an estimated 1.3 billion people or 16% of the global population have a significant disability. A disability is a condition that can be mental or physical, and can affect a person's vision, movement, thinking, learning, communication, hearing, mental health or social relationships. However, not all disabilities are the same. Some disabilities are genetic, passed down from generation to generation, while others may have been caused by an incident out of the person's control. In this episode of Exploring Ethics, Professor Joseph Stramondo will discuss the narrative, identity and ethics of choosing disability. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 40241]

According to the World Health Organization (WHO) an estimated 1.3 billion people or 16% of the global population have a significant disability. A disability is a condition that can be mental or physical, and can affect a person's vision, movement, thinking, learning, communication, hearing, mental health or social relationships. However, not all disabilities are the same. Some disabilities are genetic, passed down from generation to generation, while others may have been caused by an incident out of the person's control. In this episode of Exploring Ethics, Professor Joseph Stramondo will discuss the narrative, identity and ethics of choosing disability. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 40241]

According to the World Health Organization (WHO) an estimated 1.3 billion people or 16% of the global population have a significant disability. A disability is a condition that can be mental or physical, and can affect a person's vision, movement, thinking, learning, communication, hearing, mental health or social relationships. However, not all disabilities are the same. Some disabilities are genetic, passed down from generation to generation, while others may have been caused by an incident out of the person's control. In this episode of Exploring Ethics, Professor Joseph Stramondo will discuss the narrative, identity and ethics of choosing disability. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 40241]

According to the World Health Organization (WHO) an estimated 1.3 billion people or 16% of the global population have a significant disability. A disability is a condition that can be mental or physical, and can affect a person's vision, movement, thinking, learning, communication, hearing, mental health or social relationships. However, not all disabilities are the same. Some disabilities are genetic, passed down from generation to generation, while others may have been caused by an incident out of the person's control. In this episode of Exploring Ethics, Professor Joseph Stramondo will discuss the narrative, identity and ethics of choosing disability. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 40241]

According to the World Health Organization (WHO) an estimated 1.3 billion people or 16% of the global population have a significant disability. A disability is a condition that can be mental or physical, and can affect a person's vision, movement, thinking, learning, communication, hearing, mental health or social relationships. However, not all disabilities are the same. Some disabilities are genetic, passed down from generation to generation, while others may have been caused by an incident out of the person's control. In this episode of Exploring Ethics, Professor Joseph Stramondo will discuss the narrative, identity and ethics of choosing disability. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 40241]

Almost every child born in the United States undergoes state-mandated newborn screening within the first 48 hours of life. The blood collected from a "heel stick" helps test for 80 different serious but treatable genetic disorders. These disorders can be either genetic (passed down in families) or congenital (present at birth). But... what if we could go further? What if we could test a newborn's entire genetic sequence? Pediatric geneticist Ingrid Holm discusses the risks, benefits, costs and ethics of genomic sequencing in newborns. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 39266]

Almost every child born in the United States undergoes state-mandated newborn screening within the first 48 hours of life. The blood collected from a "heel stick" helps test for 80 different serious but treatable genetic disorders. These disorders can be either genetic (passed down in families) or congenital (present at birth). But... what if we could go further? What if we could test a newborn's entire genetic sequence? Pediatric geneticist Ingrid Holm discusses the risks, benefits, costs and ethics of genomic sequencing in newborns. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 39266]

Almost every child born in the United States undergoes state-mandated newborn screening within the first 48 hours of life. The blood collected from a "heel stick" helps test for 80 different serious but treatable genetic disorders. These disorders can be either genetic (passed down in families) or congenital (present at birth). But... what if we could go further? What if we could test a newborn's entire genetic sequence? Pediatric geneticist Ingrid Holm discusses the risks, benefits, costs and ethics of genomic sequencing in newborns. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 39266]

Almost every child born in the United States undergoes state-mandated newborn screening within the first 48 hours of life. The blood collected from a "heel stick" helps test for 80 different serious but treatable genetic disorders. These disorders can be either genetic (passed down in families) or congenital (present at birth). But... what if we could go further? What if we could test a newborn's entire genetic sequence? Pediatric geneticist Ingrid Holm discusses the risks, benefits, costs and ethics of genomic sequencing in newborns. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 39266]

Almost every child born in the United States undergoes state-mandated newborn screening within the first 48 hours of life. The blood collected from a "heel stick" helps test for 80 different serious but treatable genetic disorders. These disorders can be either genetic (passed down in families) or congenital (present at birth). But... what if we could go further? What if we could test a newborn's entire genetic sequence? Pediatric geneticist Ingrid Holm discusses the risks, benefits, costs and ethics of genomic sequencing in newborns. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 39266]

Almost every child born in the United States undergoes state-mandated newborn screening within the first 48 hours of life. The blood collected from a "heel stick" helps test for 80 different serious but treatable genetic disorders. These disorders can be either genetic (passed down in families) or congenital (present at birth). But... what if we could go further? What if we could test a newborn's entire genetic sequence? Pediatric geneticist Ingrid Holm discusses the risks, benefits, costs and ethics of genomic sequencing in newborns. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 39266]

Almost every child born in the United States undergoes state-mandated newborn screening within the first 48 hours of life. The blood collected from a "heel stick" helps test for 80 different serious but treatable genetic disorders. These disorders can be either genetic (passed down in families) or congenital (present at birth). But... what if we could go further? What if we could test a newborn's entire genetic sequence? Pediatric geneticist Ingrid Holm discusses the risks, benefits, costs and ethics of genomic sequencing in newborns. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 39266]

Almost every child born in the United States undergoes state-mandated newborn screening within the first 48 hours of life. The blood collected from a "heel stick" helps test for 80 different serious but treatable genetic disorders. These disorders can be either genetic (passed down in families) or congenital (present at birth). But... what if we could go further? What if we could test a newborn's entire genetic sequence? Pediatric geneticist Ingrid Holm discusses the risks, benefits, costs and ethics of genomic sequencing in newborns. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 39266]

The Science & Technology Ethics Center (STEC) is proud to present a series of lectures and a panel discussion that explores the intersection of genomics, medical ethics, and patient rights. This thought-provoking session delves into the ethical considerations surrounding genetic testing, data privacy, and informed consent. It examines the challenges and opportunities presented by advancements in genomics and how they impact patient care. The panel will discuss the importance of advocating for patients' rights, ensuring equitable access to genetic information, and fostering a patient-centered approach in genomic medicine. Throughout this presentation, you will grasp a deeper understanding of the ethical complexities in genomics and the critical role of patient advocacy in shaping responsible and inclusive genomic practices. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 38940]

The Science & Technology Ethics Center (STEC) is proud to present a series of lectures and a panel discussion that explores the intersection of genomics, medical ethics, and patient rights. This thought-provoking session delves into the ethical considerations surrounding genetic testing, data privacy, and informed consent. It examines the challenges and opportunities presented by advancements in genomics and how they impact patient care. The panel will discuss the importance of advocating for patients' rights, ensuring equitable access to genetic information, and fostering a patient-centered approach in genomic medicine. Throughout this presentation, you will grasp a deeper understanding of the ethical complexities in genomics and the critical role of patient advocacy in shaping responsible and inclusive genomic practices. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 38940]

The Science & Technology Ethics Center (STEC) is proud to present a series of lectures and a panel discussion that explores the intersection of genomics, medical ethics, and patient rights. This thought-provoking session delves into the ethical considerations surrounding genetic testing, data privacy, and informed consent. It examines the challenges and opportunities presented by advancements in genomics and how they impact patient care. The panel will discuss the importance of advocating for patients' rights, ensuring equitable access to genetic information, and fostering a patient-centered approach in genomic medicine. Throughout this presentation, you will grasp a deeper understanding of the ethical complexities in genomics and the critical role of patient advocacy in shaping responsible and inclusive genomic practices. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 38940]

The Science & Technology Ethics Center (STEC) is proud to present a series of lectures and a panel discussion that explores the intersection of genomics, medical ethics, and patient rights. This thought-provoking session delves into the ethical considerations surrounding genetic testing, data privacy, and informed consent. It examines the challenges and opportunities presented by advancements in genomics and how they impact patient care. The panel will discuss the importance of advocating for patients' rights, ensuring equitable access to genetic information, and fostering a patient-centered approach in genomic medicine. Throughout this presentation, you will grasp a deeper understanding of the ethical complexities in genomics and the critical role of patient advocacy in shaping responsible and inclusive genomic practices. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 38940]

The Science & Technology Ethics Center (STEC) is proud to present a series of lectures and a panel discussion that explores the intersection of genomics, medical ethics, and patient rights. This thought-provoking session delves into the ethical considerations surrounding genetic testing, data privacy, and informed consent. It examines the challenges and opportunities presented by advancements in genomics and how they impact patient care. The panel will discuss the importance of advocating for patients' rights, ensuring equitable access to genetic information, and fostering a patient-centered approach in genomic medicine. Throughout this presentation, you will grasp a deeper understanding of the ethical complexities in genomics and the critical role of patient advocacy in shaping responsible and inclusive genomic practices. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 38940]

The Science & Technology Ethics Center (STEC) is proud to present a series of lectures and a panel discussion that explores the intersection of genomics, medical ethics, and patient rights. This thought-provoking session delves into the ethical considerations surrounding genetic testing, data privacy, and informed consent. It examines the challenges and opportunities presented by advancements in genomics and how they impact patient care. The panel will discuss the importance of advocating for patients' rights, ensuring equitable access to genetic information, and fostering a patient-centered approach in genomic medicine. Throughout this presentation, you will grasp a deeper understanding of the ethical complexities in genomics and the critical role of patient advocacy in shaping responsible and inclusive genomic practices. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 38940]

The Science & Technology Ethics Center (STEC) is proud to present a series of lectures and a panel discussion that explores the intersection of genomics, medical ethics, and patient rights. This thought-provoking session delves into the ethical considerations surrounding genetic testing, data privacy, and informed consent. It examines the challenges and opportunities presented by advancements in genomics and how they impact patient care. The panel will discuss the importance of advocating for patients' rights, ensuring equitable access to genetic information, and fostering a patient-centered approach in genomic medicine. Throughout this presentation, you will grasp a deeper understanding of the ethical complexities in genomics and the critical role of patient advocacy in shaping responsible and inclusive genomic practices. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 38940]

The Science & Technology Ethics Center (STEC) is proud to present a series of lectures and a panel discussion that explores the intersection of genomics, medical ethics, and patient rights. This thought-provoking session delves into the ethical considerations surrounding genetic testing, data privacy, and informed consent. It examines the challenges and opportunities presented by advancements in genomics and how they impact patient care. The panel will discuss the importance of advocating for patients' rights, ensuring equitable access to genetic information, and fostering a patient-centered approach in genomic medicine. Throughout this presentation, you will grasp a deeper understanding of the ethical complexities in genomics and the critical role of patient advocacy in shaping responsible and inclusive genomic practices. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 38940]

Tage S. Rai is a psychologist who studies ethics, culture, and violence. Drawing on both qualitative and experimental methods, he examines the social-relational nature of morality, its origins, and its consequences. In recent work, he has found that when perpetrators are motivated by moral sentiments, they may humanize rather than dehumanize their victims, experience greater rather than lesser self-control when harming them, and respond irrationally to material costs and benefits. Moving forward, he is especially interested in developing psychological approaches to the study of organizational and institutional violence. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 38800]

Tage S. Rai is a psychologist who studies ethics, culture, and violence. Drawing on both qualitative and experimental methods, he examines the social-relational nature of morality, its origins, and its consequences. In recent work, he has found that when perpetrators are motivated by moral sentiments, they may humanize rather than dehumanize their victims, experience greater rather than lesser self-control when harming them, and respond irrationally to material costs and benefits. Moving forward, he is especially interested in developing psychological approaches to the study of organizational and institutional violence. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 38800]

Tage S. Rai is a psychologist who studies ethics, culture, and violence. Drawing on both qualitative and experimental methods, he examines the social-relational nature of morality, its origins, and its consequences. In recent work, he has found that when perpetrators are motivated by moral sentiments, they may humanize rather than dehumanize their victims, experience greater rather than lesser self-control when harming them, and respond irrationally to material costs and benefits. Moving forward, he is especially interested in developing psychological approaches to the study of organizational and institutional violence. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 38800]

Tage S. Rai is a psychologist who studies ethics, culture, and violence. Drawing on both qualitative and experimental methods, he examines the social-relational nature of morality, its origins, and its consequences. In recent work, he has found that when perpetrators are motivated by moral sentiments, they may humanize rather than dehumanize their victims, experience greater rather than lesser self-control when harming them, and respond irrationally to material costs and benefits. Moving forward, he is especially interested in developing psychological approaches to the study of organizational and institutional violence. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 38800]

Tage S. Rai is a psychologist who studies ethics, culture, and violence. Drawing on both qualitative and experimental methods, he examines the social-relational nature of morality, its origins, and its consequences. In recent work, he has found that when perpetrators are motivated by moral sentiments, they may humanize rather than dehumanize their victims, experience greater rather than lesser self-control when harming them, and respond irrationally to material costs and benefits. Moving forward, he is especially interested in developing psychological approaches to the study of organizational and institutional violence. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 38800]

Tage S. Rai is a psychologist who studies ethics, culture, and violence. Drawing on both qualitative and experimental methods, he examines the social-relational nature of morality, its origins, and its consequences. In recent work, he has found that when perpetrators are motivated by moral sentiments, they may humanize rather than dehumanize their victims, experience greater rather than lesser self-control when harming them, and respond irrationally to material costs and benefits. Moving forward, he is especially interested in developing psychological approaches to the study of organizational and institutional violence. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 38800]

Tage S. Rai is a psychologist who studies ethics, culture, and violence. Drawing on both qualitative and experimental methods, he examines the social-relational nature of morality, its origins, and its consequences. In recent work, he has found that when perpetrators are motivated by moral sentiments, they may humanize rather than dehumanize their victims, experience greater rather than lesser self-control when harming them, and respond irrationally to material costs and benefits. Moving forward, he is especially interested in developing psychological approaches to the study of organizational and institutional violence. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 38800]

Tage S. Rai is a psychologist who studies ethics, culture, and violence. Drawing on both qualitative and experimental methods, he examines the social-relational nature of morality, its origins, and its consequences. In recent work, he has found that when perpetrators are motivated by moral sentiments, they may humanize rather than dehumanize their victims, experience greater rather than lesser self-control when harming them, and respond irrationally to material costs and benefits. Moving forward, he is especially interested in developing psychological approaches to the study of organizational and institutional violence. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 38800]

Tage S. Rai is a psychologist who studies ethics, culture, and violence. Drawing on both qualitative and experimental methods, he examines the social-relational nature of morality, its origins, and its consequences. In recent work, he has found that when perpetrators are motivated by moral sentiments, they may humanize rather than dehumanize their victims, experience greater rather than lesser self-control when harming them, and respond irrationally to material costs and benefits. Moving forward, he is especially interested in developing psychological approaches to the study of organizational and institutional violence. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 38800]

How do research communities contend with controversial science? J. Benjamin Hurlbut, Ph.D., Arizona State University, Alysson Muotri, Ph.D., UC San Diego, Matthew Porteus, M.D., Ph.D., Stanford University, and Jacob (Yaqub) Hanna, M.D., Ph.D., Weizmann Institute of Science, explore controversial case studies and the limitations of scientific deliberation/dissent/ambivalence. Series: "Stem Cell Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 38729]

How do research communities contend with controversial science? J. Benjamin Hurlbut, Ph.D., Arizona State University, Alysson Muotri, Ph.D., UC San Diego, Matthew Porteus, M.D., Ph.D., Stanford University, and Jacob (Yaqub) Hanna, M.D., Ph.D., Weizmann Institute of Science, explore controversial case studies and the limitations of scientific deliberation/dissent/ambivalence. Series: "Stem Cell Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 38729]

How do research communities contend with controversial science? J. Benjamin Hurlbut, Ph.D., Arizona State University, Alysson Muotri, Ph.D., UC San Diego, Matthew Porteus, M.D., Ph.D., Stanford University, and Jacob (Yaqub) Hanna, M.D., Ph.D., Weizmann Institute of Science, explore controversial case studies and the limitations of scientific deliberation/dissent/ambivalence. Series: "Stem Cell Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 38729]

How do research communities contend with controversial science? J. Benjamin Hurlbut, Ph.D., Arizona State University, Alysson Muotri, Ph.D., UC San Diego, Matthew Porteus, M.D., Ph.D., Stanford University, and Jacob (Yaqub) Hanna, M.D., Ph.D., Weizmann Institute of Science, explore controversial case studies and the limitations of scientific deliberation/dissent/ambivalence. Series: "Stem Cell Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 38729]

How do research communities contend with controversial science? J. Benjamin Hurlbut, Ph.D., Arizona State University, Alysson Muotri, Ph.D., UC San Diego, Matthew Porteus, M.D., Ph.D., Stanford University, and Jacob (Yaqub) Hanna, M.D., Ph.D., Weizmann Institute of Science, explore controversial case studies and the limitations of scientific deliberation/dissent/ambivalence. Series: "Stem Cell Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 38729]

How do research communities contend with controversial science? J. Benjamin Hurlbut, Ph.D., Arizona State University, Alysson Muotri, Ph.D., UC San Diego, Matthew Porteus, M.D., Ph.D., Stanford University, and Jacob (Yaqub) Hanna, M.D., Ph.D., Weizmann Institute of Science, explore controversial case studies and the limitations of scientific deliberation/dissent/ambivalence. Series: "Stem Cell Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 38729]

How do research communities contend with controversial science? J. Benjamin Hurlbut, Ph.D., Arizona State University, Alysson Muotri, Ph.D., UC San Diego, Matthew Porteus, M.D., Ph.D., Stanford University, and Jacob (Yaqub) Hanna, M.D., Ph.D., Weizmann Institute of Science, explore controversial case studies and the limitations of scientific deliberation/dissent/ambivalence. Series: "Stem Cell Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 38729]

The world is facing a health crisis due to increasing rates of obesity and diabetes, and the consequences of this pandemic will accumulate over the coming decades. Simultaneously, climate change is accelerating and is already having devastating effects that will undermine our ability to feed the world's growing population. In turn, our food systems contribute importantly to greenhouse gas emissions, water and land use, and multiple forms of pollution. Thus, a solution to feeding what will be about 10 billion people by 2050 diets that are both healthy and environmentally sustainable presents an opportunity to mitigate many global challenges. The EAT-Lancet commission addressed this challenge by defining healthy diets quantitatively, determining whether these can be produced within planetary boundaries for greenhouse gas emissions and other environmental factors, and identifying strategies to achieve these goals. Any solution must assume that we rapidly shift from fossil fuels to green energy. The commission found that global adoption of a flexitarian dietary pattern that could include up to about two servings per day of animal sourced foods, together with improvements in agricultural practices and reductions in food waste, would have major benefits for human health and allow us to stay within planetary boundaries. Achieving this will require the engagement of governments at all levels, civil society, and individuals. Series: "CARTA - Center for Academic Research and Training in Anthropogeny" [Health and Medicine] [Humanities] [Science] [Show ID: 37911]

The world is facing a health crisis due to increasing rates of obesity and diabetes, and the consequences of this pandemic will accumulate over the coming decades. Simultaneously, climate change is accelerating and is already having devastating effects that will undermine our ability to feed the world's growing population. In turn, our food systems contribute importantly to greenhouse gas emissions, water and land use, and multiple forms of pollution. Thus, a solution to feeding what will be about 10 billion people by 2050 diets that are both healthy and environmentally sustainable presents an opportunity to mitigate many global challenges. The EAT-Lancet commission addressed this challenge by defining healthy diets quantitatively, determining whether these can be produced within planetary boundaries for greenhouse gas emissions and other environmental factors, and identifying strategies to achieve these goals. Any solution must assume that we rapidly shift from fossil fuels to green energy. The commission found that global adoption of a flexitarian dietary pattern that could include up to about two servings per day of animal sourced foods, together with improvements in agricultural practices and reductions in food waste, would have major benefits for human health and allow us to stay within planetary boundaries. Achieving this will require the engagement of governments at all levels, civil society, and individuals. Series: "CARTA - Center for Academic Research and Training in Anthropogeny" [Health and Medicine] [Humanities] [Science] [Show ID: 37911]

The world is facing a health crisis due to increasing rates of obesity and diabetes, and the consequences of this pandemic will accumulate over the coming decades. Simultaneously, climate change is accelerating and is already having devastating effects that will undermine our ability to feed the world's growing population. In turn, our food systems contribute importantly to greenhouse gas emissions, water and land use, and multiple forms of pollution. Thus, a solution to feeding what will be about 10 billion people by 2050 diets that are both healthy and environmentally sustainable presents an opportunity to mitigate many global challenges. The EAT-Lancet commission addressed this challenge by defining healthy diets quantitatively, determining whether these can be produced within planetary boundaries for greenhouse gas emissions and other environmental factors, and identifying strategies to achieve these goals. Any solution must assume that we rapidly shift from fossil fuels to green energy. The commission found that global adoption of a flexitarian dietary pattern that could include up to about two servings per day of animal sourced foods, together with improvements in agricultural practices and reductions in food waste, would have major benefits for human health and allow us to stay within planetary boundaries. Achieving this will require the engagement of governments at all levels, civil society, and individuals. Series: "CARTA - Center for Academic Research and Training in Anthropogeny" [Health and Medicine] [Humanities] [Science] [Show ID: 37911]

The world is facing a health crisis due to increasing rates of obesity and diabetes, and the consequences of this pandemic will accumulate over the coming decades. Simultaneously, climate change is accelerating and is already having devastating effects that will undermine our ability to feed the world's growing population. In turn, our food systems contribute importantly to greenhouse gas emissions, water and land use, and multiple forms of pollution. Thus, a solution to feeding what will be about 10 billion people by 2050 diets that are both healthy and environmentally sustainable presents an opportunity to mitigate many global challenges. The EAT-Lancet commission addressed this challenge by defining healthy diets quantitatively, determining whether these can be produced within planetary boundaries for greenhouse gas emissions and other environmental factors, and identifying strategies to achieve these goals. Any solution must assume that we rapidly shift from fossil fuels to green energy. The commission found that global adoption of a flexitarian dietary pattern that could include up to about two servings per day of animal sourced foods, together with improvements in agricultural practices and reductions in food waste, would have major benefits for human health and allow us to stay within planetary boundaries. Achieving this will require the engagement of governments at all levels, civil society, and individuals. Series: "CARTA - Center for Academic Research and Training in Anthropogeny" [Health and Medicine] [Humanities] [Science] [Show ID: 37911]

The world is facing a health crisis due to increasing rates of obesity and diabetes, and the consequences of this pandemic will accumulate over the coming decades. Simultaneously, climate change is accelerating and is already having devastating effects that will undermine our ability to feed the world's growing population. In turn, our food systems contribute importantly to greenhouse gas emissions, water and land use, and multiple forms of pollution. Thus, a solution to feeding what will be about 10 billion people by 2050 diets that are both healthy and environmentally sustainable presents an opportunity to mitigate many global challenges. The EAT-Lancet commission addressed this challenge by defining healthy diets quantitatively, determining whether these can be produced within planetary boundaries for greenhouse gas emissions and other environmental factors, and identifying strategies to achieve these goals. Any solution must assume that we rapidly shift from fossil fuels to green energy. The commission found that global adoption of a flexitarian dietary pattern that could include up to about two servings per day of animal sourced foods, together with improvements in agricultural practices and reductions in food waste, would have major benefits for human health and allow us to stay within planetary boundaries. Achieving this will require the engagement of governments at all levels, civil society, and individuals. Series: "CARTA - Center for Academic Research and Training in Anthropogeny" [Health and Medicine] [Humanities] [Science] [Show ID: 37911]

The world is facing a health crisis due to increasing rates of obesity and diabetes, and the consequences of this pandemic will accumulate over the coming decades. Simultaneously, climate change is accelerating and is already having devastating effects that will undermine our ability to feed the world's growing population. In turn, our food systems contribute importantly to greenhouse gas emissions, water and land use, and multiple forms of pollution. Thus, a solution to feeding what will be about 10 billion people by 2050 diets that are both healthy and environmentally sustainable presents an opportunity to mitigate many global challenges. The EAT-Lancet commission addressed this challenge by defining healthy diets quantitatively, determining whether these can be produced within planetary boundaries for greenhouse gas emissions and other environmental factors, and identifying strategies to achieve these goals. Any solution must assume that we rapidly shift from fossil fuels to green energy. The commission found that global adoption of a flexitarian dietary pattern that could include up to about two servings per day of animal sourced foods, together with improvements in agricultural practices and reductions in food waste, would have major benefits for human health and allow us to stay within planetary boundaries. Achieving this will require the engagement of governments at all levels, civil society, and individuals. Series: "CARTA - Center for Academic Research and Training in Anthropogeny" [Health and Medicine] [Humanities] [Science] [Show ID: 37911]

The world is facing a health crisis due to increasing rates of obesity and diabetes, and the consequences of this pandemic will accumulate over the coming decades. Simultaneously, climate change is accelerating and is already having devastating effects that will undermine our ability to feed the world's growing population. In turn, our food systems contribute importantly to greenhouse gas emissions, water and land use, and multiple forms of pollution. Thus, a solution to feeding what will be about 10 billion people by 2050 diets that are both healthy and environmentally sustainable presents an opportunity to mitigate many global challenges. The EAT-Lancet commission addressed this challenge by defining healthy diets quantitatively, determining whether these can be produced within planetary boundaries for greenhouse gas emissions and other environmental factors, and identifying strategies to achieve these goals. Any solution must assume that we rapidly shift from fossil fuels to green energy. The commission found that global adoption of a flexitarian dietary pattern that could include up to about two servings per day of animal sourced foods, together with improvements in agricultural practices and reductions in food waste, would have major benefits for human health and allow us to stay within planetary boundaries. Achieving this will require the engagement of governments at all levels, civil society, and individuals. Series: "CARTA - Center for Academic Research and Training in Anthropogeny" [Health and Medicine] [Humanities] [Science] [Show ID: 37911]

The world is facing a health crisis due to increasing rates of obesity and diabetes, and the consequences of this pandemic will accumulate over the coming decades. Simultaneously, climate change is accelerating and is already having devastating effects that will undermine our ability to feed the world's growing population. In turn, our food systems contribute importantly to greenhouse gas emissions, water and land use, and multiple forms of pollution. Thus, a solution to feeding what will be about 10 billion people by 2050 diets that are both healthy and environmentally sustainable presents an opportunity to mitigate many global challenges. The EAT-Lancet commission addressed this challenge by defining healthy diets quantitatively, determining whether these can be produced within planetary boundaries for greenhouse gas emissions and other environmental factors, and identifying strategies to achieve these goals. Any solution must assume that we rapidly shift from fossil fuels to green energy. The commission found that global adoption of a flexitarian dietary pattern that could include up to about two servings per day of animal sourced foods, together with improvements in agricultural practices and reductions in food waste, would have major benefits for human health and allow us to stay within planetary boundaries. Achieving this will require the engagement of governments at all levels, civil society, and individuals. Series: "CARTA - Center for Academic Research and Training in Anthropogeny" [Health and Medicine] [Humanities] [Science] [Show ID: 37911]

Climate change is one of the hallmarks of the Anthropocene. Rising global temperatures are having profound effects on ecosystems and the organisms that inhabit them, including disease-causing organisms such as viruses, bacteria, and parasitic worms. However, much less is known about the potential for infectious agents to contribute to changes in climate. Many infectious agents have the potential to affect greenhouse gas emissions via effects on their hosts. In her talk, Vanessa Ezenwa explores the idea that interactions between climate change and infectious diseases are not solely unidirectional, specifically, that climate change can increase disease prevalence in human and animal populations, but disease, in turn, may exacerbate climate change. Series: "CARTA - Center for Academic Research and Training in Anthropogeny" [Health and Medicine] [Humanities] [Science] [Show ID: 37774]

Climate change is one of the hallmarks of the Anthropocene. Rising global temperatures are having profound effects on ecosystems and the organisms that inhabit them, including disease-causing organisms such as viruses, bacteria, and parasitic worms. However, much less is known about the potential for infectious agents to contribute to changes in climate. Many infectious agents have the potential to affect greenhouse gas emissions via effects on their hosts. In her talk, Vanessa Ezenwa explores the idea that interactions between climate change and infectious diseases are not solely unidirectional, specifically, that climate change can increase disease prevalence in human and animal populations, but disease, in turn, may exacerbate climate change. Series: "CARTA - Center for Academic Research and Training in Anthropogeny" [Health and Medicine] [Humanities] [Science] [Show ID: 37774]

Climate change is one of the hallmarks of the Anthropocene. Rising global temperatures are having profound effects on ecosystems and the organisms that inhabit them, including disease-causing organisms such as viruses, bacteria, and parasitic worms. However, much less is known about the potential for infectious agents to contribute to changes in climate. Many infectious agents have the potential to affect greenhouse gas emissions via effects on their hosts. In her talk, Vanessa Ezenwa explores the idea that interactions between climate change and infectious diseases are not solely unidirectional, specifically, that climate change can increase disease prevalence in human and animal populations, but disease, in turn, may exacerbate climate change. Series: "CARTA - Center for Academic Research and Training in Anthropogeny" [Health and Medicine] [Humanities] [Science] [Show ID: 37774]